Cocaine and its metabolites in the placenta: a systematic review of the literature

Reprod Toxicol. 2012 Jan;33(1):1-14. doi: 10.1016/j.reprotox.2011.10.012. Epub 2011 Nov 6.

Abstract

It is clear that cocaine and cocaine metabolites are present in the placenta and may harm the fetus. The results of the experimental manipulation of cocaine exposure are not reported in the literature in a consistent manner. We conducted a systematic review of selected articles that demonstrated the analytical detection of cocaine and its metabolites in the placenta and that were published from January 1, 1956-June 30, 2011 using Medline, Toxline and Scopus databases. The collected data confirm that the placenta does not act as a barrier to fetal exposure, that cocaine quickly crosses the placenta and that one of the essential roles of the placenta is to metabolize cocaine during pregnancy. Our systematic review summarized the results showing that cocaine, benzoylecgonine and norcocaine are stored in the myometrium and the placental membrane and maintain continuous drug delivery to the amniotic fluid (and to the fetus) probably via diffusion.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Amniotic Fluid / metabolism
  • Animals
  • Biological Assay
  • Biotransformation
  • Central Nervous System Stimulants / adverse effects
  • Central Nervous System Stimulants / blood
  • Central Nervous System Stimulants / pharmacokinetics*
  • Cocaine / adverse effects
  • Cocaine / blood
  • Cocaine / pharmacokinetics*
  • Cocaine-Related Disorders / blood
  • Cocaine-Related Disorders / complications
  • Cocaine-Related Disorders / metabolism*
  • Diffusion
  • Female
  • Fetal Blood / metabolism
  • Humans
  • Maternal-Fetal Exchange
  • Myometrium / metabolism
  • Placenta / metabolism*
  • Placental Circulation
  • Pregnancy
  • Pregnancy Complications / chemically induced

Substances

  • Central Nervous System Stimulants
  • Cocaine